Treatment protocol duration: how long to use GHK-Cu Determining optimal treatment length for different goals
The new Wegovy 7.2mg dose is now licensed and available
Moderator: - Daragh Connolly, Chair, FIP Board of Pharmaceutical Practice, International Pharmaceutical Federation, Ireland Panellists: - Andrea Vassalotti, Senior Director, Partnerships & Programmes, World Heart Federation, Switzerland - Nesligul Ozdemir Ayduran, Assistant Professor, Gazi University, Faculty of Pharmacy, Department of Clinical Pharmacy, Trkiye - Ross Tsuyuki, Professor of Medicine (Cardiology) and Director, EPICORE Centre, Faculty of Medicine and Dentistry, University of Alberta, Canada - Ins Nunes da Cunha, Practice Development and Transformation Manager, FIP, The Netherlands - Gamze Nur Songur, FIP Intern, FIP, The Netherlands Watch video Digital event video 24 September 2025, 13:00 - 14:30 CEST Demystifying AI- Foundations and Opportunities More Artificial Intelligence (AI) is reshaping healthcare, including pharmacy practice
Improved Weight Loss: Studies show that Tirzepatide leads to significant weight loss in patients, with many individuals losing over 15% of their body weight
Stay Hydrated and Get Adequate Sleep Hydration and sleep are often overlooked but carry real influence during GLP-1 therapy
The study did not find a correlation between whole-blood serotonin levels and sleep or emotional problems
